3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
86
Recurrence
18
Neoplasms
6
Neoplasms, Plasma Cell
3
Lymphoma, Non-Hodgkin
3
Sarcoma, Kaposi
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Immunoglobulin Light-chain Amyloidosis
2
Chromosome 17 deletion
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Waldenstrom Macroglobulinemia
1
Smoldering Multiple Myeloma
1
Proteostasis Deficiencies
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myelomonocytic, Chronic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Epstein-Barr Virus Infections
1
Interventions
Temozolomide
42
Magnetic Resonance Spectroscopy
41
Radiotherapy
22
Specimen Handling
18
Biopsy
13
X-Rays
10
Radiation
10
trametinib
8
Bevacizumab
8
Nivolumab
7
Blood Specimen Collection
7
olaparib
6
fluorodopa F 18
6
dabrafenib
6
Radiotherapy, Intensity-Modulated
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Lomustine
6
pembrolizumab
5
abemaciclib
5
Standard of Care
5
vorasidenib
4
ulixertinib
4
larotrectinib
4
ivosidenib
4
erdafitinib
4
Surgical Procedures, Operative
4
Dianhydrogalactitol
4
Cyclophosphamide
4
Aminolevulinic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
pomalidomide
×
1 year
×
Clear all
No trials found.